BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

349 related articles for article (PubMed ID: 30257686)

  • 1. Cardiovascular magnetic resonance evidence of myocardial fibrosis and its clinical significance in adolescent and adult patients with Ebstein's anomaly.
    Yang D; Li X; Sun JY; Cheng W; Greiser A; Zhang TJ; Liu H; Wan K; Luo Y; An Q; Chung YC; Han Y; Chen YC
    J Cardiovasc Magn Reson; 2018 Sep; 20(1):69. PubMed ID: 30257686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Left ventricular synchrony, torsion, and recoil mechanics in Ebstein's anomaly: insights from cardiovascular magnetic resonance.
    Steinmetz M; Usenbenz S; Kowallick JT; Hösch O; Staab W; Lange T; Kutty S; Lotz J; Hasenfuß G; Paul T; Schuster A
    J Cardiovasc Magn Reson; 2017 Dec; 19(1):101. PubMed ID: 29237468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern and prognostic value of cardiac involvement in patients with late-onset pompe disease: a comprehensive cardiovascular magnetic resonance approach.
    Boentert M; Florian A; Dräger B; Young P; Yilmaz A
    J Cardiovasc Magn Reson; 2016 Dec; 18(1):91. PubMed ID: 27931223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical aspects of myocardial fibrosis in adults with Ebstein's anomaly.
    Ciepłucha A; Trojnarska O; Kociemba A; Łanocha M; Barczynski M; Rozmiarek S; Kramer L; Pyda M
    Heart Vessels; 2018 Sep; 33(9):1076-1085. PubMed ID: 29468473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial Fibrosis in Pediatric Patients With Ebstein's Anomaly.
    Aly S; Seed M; Yoo SJ; Lam C; Grosse-Wortmann L
    Circ Cardiovasc Imaging; 2021 Mar; 14(3):e011136. PubMed ID: 33722068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The prognostic value of T1 mapping and late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with light chain amyloidosis.
    Lin L; Li X; Feng J; Shen KN; Tian Z; Sun J; Mao YY; Cao J; Jin ZY; Li J; Selvanayagam JB; Wang YN
    J Cardiovasc Magn Reson; 2018 Jan; 20(1):2. PubMed ID: 29298704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy.
    Latus H; Gummel K; Klingel K; Moysich A; Khalil M; Mazhari N; Bauer J; Kandolf R; Schranz D; Apitz C
    J Cardiovasc Magn Reson; 2015 May; 17(1):34. PubMed ID: 25976093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection and evaluation of myocardial fibrosis in Eisenmenger syndrome using cardiovascular magnetic resonance late gadolinium enhancement and T1 mapping.
    Gong C; Guo J; Wan K; Wang L; Chen X; Guo J; He J; Yin L; Wen B; Pu S; Chen C; Chen Y
    J Cardiovasc Magn Reson; 2022 Nov; 24(1):60. PubMed ID: 36404313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Left Ventricular Myocardial Fibrosis in Adult Patients With Ebstein Anomaly: A Retrospective Cohort Study Based on Cardiac Magnetic Resonance and Histopathological Samples.
    Fernandez-Badillo V; Serrano-Roman J; Antonio-Villa NE; Cabello-Ganem A; Espejel-Guzman A; Torres-Araujo LV; Aranda-Fraustro A; Cano-Zarate R; Solorzano-Pinot E; Keirns C; Meave-Gonzalez A; Alexanderson-Rosas E; Espinola-Zavaleta N
    Circ Cardiovasc Imaging; 2023 May; 16(5):e015011. PubMed ID: 37154028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Left ventricular function recovery in peripartum cardiomyopathy: a cardiovascular magnetic resonance study by myocardial T1 and T2 mapping.
    Liang YD; Xu YW; Li WH; Wan K; Sun JY; Lin JY; Zhang Q; Zhou XY; Chen YC
    J Cardiovasc Magn Reson; 2020 Jan; 22(1):2. PubMed ID: 31902370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myocardial fibrosis as a key determinant of left ventricular remodeling in idiopathic dilated cardiomyopathy: a contrast-enhanced cardiovascular magnetic study.
    Masci PG; Schuurman R; Andrea B; Ripoli A; Coceani M; Chiappino S; Todiere G; Srebot V; Passino C; Aquaro GD; Emdin M; Lombardi M
    Circ Cardiovasc Imaging; 2013 Sep; 6(5):790-9. PubMed ID: 23934992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing CMR Mapping Methods and Myocardial Patterns Toward Heart Failure Outcomes in Nonischemic Dilated Cardiomyopathy.
    Vita T; Gräni C; Abbasi SA; Neilan TG; Rowin E; Kaneko K; Coelho-Filho O; Watanabe E; Mongeon FP; Farhad H; Rassi CH; Choi YL; Cheng K; Givertz MM; Blankstein R; Steigner M; Aghayev A; Jerosch-Herold M; Kwong RY
    JACC Cardiovasc Imaging; 2019 Aug; 12(8 Pt 2):1659-1669. PubMed ID: 30448130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological validation of cardiovascular magnetic resonance T1 mapping markers of myocardial fibrosis in paediatric heart transplant recipients.
    Ide S; Riesenkampff E; Chiasson DA; Dipchand AI; Kantor PF; Chaturvedi RR; Yoo SJ; Grosse-Wortmann L
    J Cardiovasc Magn Reson; 2017 Feb; 19(1):10. PubMed ID: 28143545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrio-ventricular deformation and heart failure in Ebstein's Anomaly - A cardiovascular magnetic resonance study.
    Steinmetz M; Broder M; Hösch O; Lamata P; Kutty S; Kowallick JT; Staab W; Ritter CO; Hasenfuß G; Paul T; Lotz J; Schuster A
    Int J Cardiol; 2018 Apr; 257():54-61. PubMed ID: 29402525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial ECV Fraction Assessed by CMR Is Associated With Type of Hemodynamic Load and Arrhythmia in Repaired Tetralogy of Fallot.
    Chen CA; Dusenbery SM; Valente AM; Powell AJ; Geva T
    JACC Cardiovasc Imaging; 2016 Jan; 9(1):1-10. PubMed ID: 26684969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of elevated right ventricular extracellular volume in pulmonary hypertension using Accelerated and Navigator-Gated Look-Locker Imaging for Cardiac T1 Estimation (ANGIE) cardiovascular magnetic resonance.
    Mehta BB; Auger DA; Gonzalez JA; Workman V; Chen X; Chow K; Stump CJ; Mazimba S; Kennedy JL; Gay E; Salerno M; Kramer CM; Epstein FH; Bilchick KC
    J Cardiovasc Magn Reson; 2015 Dec; 17():110. PubMed ID: 26692265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diffuse Myocardial Fibrosis and Inflammation in Rheumatoid Arthritis: Insights From CMR T1 Mapping.
    Ntusi NAB; Piechnik SK; Francis JM; Ferreira VM; Matthews PM; Robson MD; Wordsworth PB; Neubauer S; Karamitsos TD
    JACC Cardiovasc Imaging; 2015 May; 8(5):526-536. PubMed ID: 25890584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebral vascular resistance and left ventricular myocardial performance in fetuses with Ebstein's anomaly.
    Chen Y; Lv G; Li B; Wang Z
    Am J Perinatol; 2009 Apr; 26(4):253-8. PubMed ID: 19023852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T1 and T2 mapping for evaluation of myocardial involvement in patients with ANCA-associated vasculitides.
    Greulich S; Mayr A; Kitterer D; Latus J; Henes J; Steubing H; Kaesemann P; Patrascu A; Greiser A; Groeninger S; Braun N; Alscher MD; Sechtem U; Mahrholdt H
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):6. PubMed ID: 28077133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.